Rahali; Houcine
Patent Applications and Registrations
Patent applications and USPTO patent grants for Rahali; Houcine.The latest application filed is for "antiviral aryl-amide phosphodiamide compounds".
- Rahali; Houcine - Saint Laurent des Arbres FR
- Rahali; Houcine - St Laurent des Arbres N/A FR
| Patent | Date |
|---|---|
| Antiviral aryl-amide phosphodiamide compounds Grant 10,736,908 - Paparin , et al. A | 2020-08-11 |
| Antiviral aliphatic ester prodrugs of tenofovir Grant 10,519,159 - Paparin , et al. Dec | 2019-12-31 |
| 2'-chloro nucleoside analogs for HCV infection Grant 10,513,534 - Gosselin , et al. Dec | 2019-12-24 |
| Antiviral prodrugs of tenofovir Grant 10,449,208 - Da Costa , et al. Oc | 2019-10-22 |
| Antiviral Aryl-amide Phosphodiamide Compounds App 20190262365 - Paparin; Jean-Laurent ; et al. | 2019-08-29 |
| Antiviral Prodrugs Of Tenofovir App 20190183912 - Da Costa; Daniel ; et al. | 2019-06-20 |
| D-amino Acid Compounds For Liver Disease App 20180258130 - MAYES; Benjamin Alexander ; et al. | 2018-09-13 |
| Antiviral Aliphatic Ester Prodrugs Of Tenofovir App 20180179208 - Paparin; Jean-Laurent ; et al. | 2018-06-28 |
| 3',5'-cyclic phosphate prodrugs for HCV infection Grant 9,296,778 - Parsy , et al. March 29, 2 | 2016-03-29 |
| 2'-chloro Nucleoside Analogs For Hcv Infection App 20160083413 - Gosselin; Gilles ; et al. | 2016-03-24 |
| D-amino Acid Compounds For Liver Disease App 20160002281 - MAYES; Benjamin Alexander ; et al. | 2016-01-07 |
| 5,5-fused arylene or heteroarylene hepatitis C virus inhibitors Grant 9,187,496 - Dousson , et al. November 17, 2 | 2015-11-17 |
| 2'-chloro Nucleoside Analogs For Hcv Infection App 20140099283 - GOSSELIN; Gilles ; et al. | 2014-04-10 |
| 3',5'-cyclic Phosphate Prodrugs For Hcv Infection App 20130315867 - PARSY; Christophe Claude ; et al. | 2013-11-28 |
| Pyrroloquinoline derivatives and their use as protein kinases inhibitors Grant 8,426,437 - Bienayme , et al. April 23, 2 | 2013-04-23 |
| 5,5-fused Arylene Or Heteroarylene Hepatitis C Virus Inhibitors App 20130071352 - Dousson; Cyril B. ; et al. | 2013-03-21 |
| 5,5-fused arylene or heteroarylene hepatitis C virus inhibitors Grant 8,362,068 - Dousson , et al. January 29, 2 | 2013-01-29 |
| Methods For Treating Drug-resistant Hepatitis C Virus Infection With A 5,5-fused Arylene Or Heteroarylene Hepatitis C Virus Inhibitor App 20120252721 - Dousson; Cyril B. ; et al. | 2012-10-04 |
| 5,5-fused Arylene Or Heteroarylene Hepatitis C Virus Inhibitors App 20110150827 - Dousson; Cyril B. ; et al. | 2011-06-23 |
| Pyrroloquinoline Derivatives And Their Use As Protein Kinases Inhibitors App 20090042876 - Bienayme; Hugues ; et al. | 2009-02-12 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 